These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17959936)

  • 1. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.
    Detmer SA; Vande Velde C; Cleveland DW; Chan DC
    Hum Mol Genet; 2008 Feb; 17(3):367-75. PubMed ID: 17959936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
    Franco A; Dang X; Walton EK; Ho JN; Zablocka B; Ly C; Miller TM; Baloh RH; Shy ME; Yoo AS; Dorn GW
    Elife; 2020 Oct; 9():. PubMed ID: 33074106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
    Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
    Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle.
    Bannerman P; Burns T; Xu J; Miers L; Pleasure D
    PLoS One; 2016; 11(12):e0167573. PubMed ID: 27907123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
    Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
    J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
    Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
    J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.
    Saporta MA; Dang V; Volfson D; Zou B; Xie XS; Adebola A; Liem RK; Shy M; Dimos JT
    Exp Neurol; 2015 Jan; 263():190-9. PubMed ID: 25448007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator.
    Weigele J; Zhang L; Franco A; Cartier E; Dorn GW
    J Pharmacol Exp Ther; 2024 Oct; 391(2):361-374. PubMed ID: 39284622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
    Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
    Elife; 2023 Nov; 12():. PubMed ID: 37910431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish.
    Chapman AL; Bennett EJ; Ramesh TM; De Vos KJ; Grierson AJ
    PLoS One; 2013; 8(6):e67276. PubMed ID: 23840650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitofusin gain and loss of function drive pathogenesis in
    El Fissi N; Rojo M; Aouane A; Karatas E; Poliacikova G; David C; Royet J; Rival T
    EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29898954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mfn2
    Zhang Y; Ma L; Wang Z; Gao C; Yang L; Li M; Tang X; Yuan H; Pang D; Ouyang H
    Int J Biol Macromol; 2024 Oct; 278(Pt 1):134673. PubMed ID: 39142491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
    Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
    J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
    Detmer SA; Chan DC
    J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons.
    Rizzo F; Ronchi D; Salani S; Nizzardo M; Fortunato F; Bordoni A; Stuppia G; Del Bo R; Piga D; Fato R; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2016 Oct; 25(19):4266-4281. PubMed ID: 27506976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy.
    Bernard-Marissal N; van Hameren G; Juneja M; Pellegrino C; Louhivuori L; Bartesaghi L; Rochat C; El Mansour O; Médard JJ; Croisier M; Maclachlan C; Poirot O; Uhlén P; Timmerman V; Tricaud N; Schneider BL; Chrast R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2328-2337. PubMed ID: 30659145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.
    Zhou Y; Carmona S; Muhammad AKMG; Bell S; Landeros J; Vazquez M; Ho R; Franco A; Lu B; Dorn GW; Wang S; Lutz CM; Baloh RH
    J Clin Invest; 2019 Mar; 129(4):1756-1771. PubMed ID: 30882371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.